A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitis

OBJECTIVE: The study was designed to evaluate the efficacy of an ophthalmic formulation of 1% azithromycin in DuraSite(®) (AzaSite™, InSite Vision, Alameda CA, USA) and demonstrate equivalence with 0.3% tobramycin ophthalmic solution, USP, for the treatment of bacterial conjunctivitis as defined by...

Descripción completa

Detalles Bibliográficos
Autores principales: Abelson, Mark, Protzko, Eugene, Shapiro, Aron, Garces-Soldana, Ana, Bowman, Lyle
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704516/
https://www.ncbi.nlm.nih.gov/pubmed/19668507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704516/
https://www.ncbi.nlm.nih.gov/pubmed/19668507

Ejemplares similares